Jazz Pharmaceuticals plc — Director's Dealing 2022

Jan 5, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Jazz Pharmaceuticals plc (JAZZ)
CIK: 0001232524
Period of Report: 2022-01-03

Reporting Person: Swisher Daniel N JR (President and COO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-01-03	Ordinary Shares	F	1624	$131.01	Disposed	48546	Direct

Footnotes

F1: Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units.

F2: Includes 147 and 62 ordinary shares acquired under a Section 423 Employee Stock Purchase Plan on May 28 and November 30, 2021, respectively.